Endoscopic ultrasound screening for people at high risk of pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study uses a special endoscopic ultrasound to screen people at high risk for pancreatic cancer and follows them over time to catch cancer early or prevent it. If you have certain risk factors, you may be eligible to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are considered at high risk for pancreatic cancer (for example, past pancreatitis, family history, or certain genetic conditions).
- You have no serious heart or lung disease, bleeding problems, or other issues that would make an endoscopic procedure unsafe.
- You are willing to have endoscopic ultrasound (EUS) exams as part of the study.
- You can understand the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study is looking at healthy adults who have no symptoms or risk factors for pancreatic cancer to test a new imaging method that may help find early signs of the disease. If you join, you will have an endoscopic ultrasound (a thin tube with a camera passed to your stomach) to check your pancreas.
This study looks at how doctors use endoscopic ultrasound (EUS) to diagnose and manage tumors in the pancreas and nearby areas. If you have such a tumor, this study may help improve how these conditions are treated.
This trial uses a special ultrasound test to collect cells from a pancreatic tumor and study them to better predict if the cancer may come back or spread. It aims to help doctors choose the best treatment plan for each person.
This study looks for people at high risk for pancreatic cancer, either because of family history, certain genetic mutations, or concerning pancreatic cysts. Researchers want to follow you over time to find cancer early, when it's easier to treat.
Hear when a new Carcinoma, Pancreatic Ductal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.